In terms of the relationships of AMPK and IDH mutation, previous reports demonstrated the metabolic vulnerability of mutant IDH gliomas or glioblastomas to biguanides, such as metformin and phenformin, which activate AMPK by inhibiting mitochondrial respiratory chain complex 147–49. This evidence concerns the gene IDH2 and central nervous system cancer.